Clinical trial
Cytomegalovirus Retinitis Retreatment Trial
NCT00000134 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cytomegalovirus Retinitis Retreatment Trial
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 1992
- Completion date
- March 31, 1995
- Enrollment
- 279 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.